Event News & Resources
Catalina Vigil Cardenal’s farewell message
"My time at Neuro-Bio has come to an end, and I want to say how truly grateful I am for the past year. Starting out as a Junior Scientist, I expected to develop my lab skills and deepen my understanding of experimental work, and I certainly achieved that. But what...
Neuro-Bio will participate in the BioSeed 2022 event in London
On Tuesday 25th of January 2022, Neuro-Bio's CEO Susan Greenfield, Scientific Director Paul Morrill and Operations' Director Sara Garcia-Rates will participate in the BioSeed 2022 event that will take place in London. Click the link for more information or to register...
Susan Greenfield debate at the House of Lords on 20/10/2021
On Wednesday 20th October Susan Greenfield, Neuro-Bio Ltd's CEO will have a debate at the House of Lords regarding the following topic: "Ageing: Science, Technology and Healthy Living". Click the link to see the report, or use the following link to read the speech....
New collaboration with Dr Nadine Kabbani.
Neuro-Bio is delighted to announce a new collaboration with Dr Nadine Kabbani at George Mason University in Virginia. This is what she said about the project: "My group is interested in how calcium signalling by the alpha 7 type nicotinic receptor influences synaptic...
Mehreen joins Neuro-Bio !
Neuro-Bio welcomes Mehreen Ahmed as part of the team ! Mehreen is currently in her third year studying Neuroscience at the University of Nottingham as part of her sandwich year in industry and currently working as an intern for Neuro-Bio. She hopes to gain an insight...
Tumisang joins Neuro-Bio!
Neuro-Bio welcomes Tumisang Moswete as part of the team! Tumisang is currently in her third year of her MBiol Pharmacology course at Nottingham Trent University, and currently working as an intern for Neuro-Bio. She was drawn to Neuro-Bio because of the extensive...
Neuro-Bio mentioned on Mergermarket, an ACURIS company.
Neuro-Bio was mentioned on 2 articles on August the 27th on Mergermarket, an ACURIS company. Please find here the full article on Neuro-Bio’s fundraising plans: Neuro-Bio seeks to raise GBP 10m Series C by 1H22 for Alzheimer’s peptide drug – CEO _ Mergermarket And...